SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: betty moyers who wrote (21160)4/22/1999 7:18:00 AM
From: Mkilloran  Respond to of 23519
 
betty...VVUS selling at 4.80 EU in Germany ,,,$5.08 USA

everyone be patient.........

2nd qtr will be similar to the first qtr.....0.12 eps

Unless they sign a USA or Japan partner (then it will be alot better)..

Astra/Zeneca launches Muse sales n Germany in 2 weeks
Alibra will complete Phase III trials and be submitted for NDA this year

PE drug will start testing on humans this year

Look for $4 million in additional milestones from (Spain, Italy) soon
Look for Janssen's $2 milion milestone for China next qtr

Please read the latest studies and abstracts....growing R&D
MUSE Safety, combo Viagra & MUSE treatment, success of Muse in Viagra failures,Female SD progress, advances in Gene therapy foe ED and NON-ED use..........

Have a nice day